• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

确定与疟疾和疟疾化学预防相关的效用值。

Determining utility values related to malaria and malaria chemoprophylaxis.

机构信息

Tropical Medicine and International Health Clinic, Division of Infectious Diseases Ottawa Hospital General Campus, University of Ottawa, 501 Smyth Road, Ottawa, Ontario K1H 8L6, Canada.

出版信息

Malar J. 2010 Apr 9;9:92. doi: 10.1186/1475-2875-9-92.

DOI:10.1186/1475-2875-9-92
PMID:20380717
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2865502/
Abstract

BACKGROUND

Chemoprophylaxis for travellers' malaria is problematic. Decision modeling may help determine optimal prevention strategies for travellers' malaria. Such models can fully assess effect of drug use and disease on quality of life, and help travellers make informed values based decisions. Such models require utility values reflecting societal preferences over different health states of relevance. To date, there are no published utility values relating to clinical malaria or chemoprophylaxis adverse events.

METHODS

Utility estimates for health states related to falciparum malaria, sequelae and drug-related adverse events were obtained using a self-administered visual analogue scale in 20 individuals. Utility values for health states related to clinical malaria were obtained from a survey of 11 malaria experts questioned about length of hospital stay or equivalent disability with simple and severe travellers' malaria.

RESULTS

The general public (potential travellers), were more tolerant of taking prophylaxis if associated with no or mild AEs and least tolerant of mild sequelae from malaria and severe drug related events. The rating value reported for taking no prophylaxis was quite variable. Tropical medicine specialists estimated a mean hospital stay 3.23 days (range 0.5-4.5 days) for simple and 6.36 days (range 4.5-7 days) for severe malaria.

CONCLUSIONS

This study provides a benchmark for important utility value estimates for modeling malaria and drug-related outcomes in non-immune travellers.

摘要

背景

旅行者疟疾的化学预防存在问题。决策模型可能有助于确定旅行者疟疾的最佳预防策略。此类模型可以充分评估药物使用和疾病对生活质量的影响,并帮助旅行者根据自身价值观做出明智的决策。此类模型需要反映出社会对相关健康状况的偏好的效用值。迄今为止,尚无与临床疟疾或化学预防不良事件相关的已发表的效用值。

方法

使用 20 名个体的自我管理视觉模拟量表获得与恶性疟原虫疟疾、后遗症和药物相关不良事件相关的健康状况的效用估计值。通过对 11 名疟疾专家进行的一项调查,获得与临床疟疾相关的健康状况的效用值,该调查询问了简单和严重旅行者疟疾的住院时间或同等残疾的长度。

结果

一般公众(潜在旅行者)如果与无或轻度 AE 相关,更能容忍服用预防药物,而最不能容忍疟疾的轻度后遗症和严重的药物相关事件。报告的不服用预防药物的评分值差异很大。热带医学专家估计,简单疟疾的平均住院时间为 3.23 天(范围为 0.5-4.5 天),严重疟疾的平均住院时间为 6.36 天(范围为 4.5-7 天)。

结论

本研究为非免疫旅行者疟疾和药物相关结局建模提供了重要的效用值基准估计。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3977/2865502/158595c5f3bb/1475-2875-9-92-1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3977/2865502/158595c5f3bb/1475-2875-9-92-1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3977/2865502/158595c5f3bb/1475-2875-9-92-1.jpg

相似文献

1
Determining utility values related to malaria and malaria chemoprophylaxis.确定与疟疾和疟疾化学预防相关的效用值。
Malar J. 2010 Apr 9;9:92. doi: 10.1186/1475-2875-9-92.
2
Comparative benefit of malaria chemoprophylaxis modelled in United Kingdom travellers.英国旅行者疟疾化学预防模型的比较获益。
Travel Med Infect Dis. 2014 Nov-Dec;12(6 Pt B):726-32. doi: 10.1016/j.tmaid.2014.08.005.
3
Recommendations for malaria prevention in moderate to low risk areas: travellers' choice and risk perception.中低风险地区疟疾预防建议:旅行者的选择与风险认知
Malar J. 2015 Apr 1;14:139. doi: 10.1186/s12936-015-0654-y.
4
Effectiveness of malaria chemoprophylaxis against Plasmodium falciparum infection in UK travellers: retrospective observational data.英国旅行者疟疾化学预防对恶性疟原虫感染的效果:回顾性观察数据。
Travel Med Infect Dis. 2009 Nov;7(6):329-36. doi: 10.1016/j.tmaid.2009.10.002. Epub 2009 Nov 3.
5
Stand-by emergency treatment (SBET) of malaria in Spanish travellers: a cohort study.西班牙旅行者疟疾的备用急救治疗(SBET):一项队列研究。
Malar J. 2018 Apr 2;17(1):134. doi: 10.1186/s12936-018-2304-7.
6
Malaria knowledge and utilization of chemoprophylaxis in the UK population and in UK passengers departing to malaria-endemic areas.英国人口和前往疟疾流行地区的英国旅客对疟疾的认识和化学预防措施的利用情况。
Malar J. 2013 Dec 21;12:461. doi: 10.1186/1475-2875-12-461.
7
Severity of imported malaria: protective effect of taking malaria chemoprophylaxis.输入的英文文本为: Severity of imported malaria: protective effect of taking malaria chemoprophylaxis. 译文:输入的英文文本的中文译文为: 输入的英文文本的译文:输入的英文文本的译文。
Malar J. 2013 Jul 31;12:265. doi: 10.1186/1475-2875-12-265.
8
Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.在流行地区,服用抗叶酸抗疟药物的人群中,叶酸补充剂与疟疾易感性和严重程度的关系。
Cochrane Database Syst Rev. 2022 Feb 1;2(2022):CD014217. doi: 10.1002/14651858.CD014217.
9
A systematic review of factors affecting adherence to malaria chemoprophylaxis amongst travellers from non-endemic countries.非疟疾流行国家旅行者服用疟疾化学预防药物的依从性影响因素的系统评价
Malar J. 2020 Jan 13;19(1):16. doi: 10.1186/s12936-020-3104-4.
10
Malaria prevention in the older traveller: a systematic review.老年人旅行者的疟疾预防:系统评价。
J Travel Med. 2019 Oct 14;26(7). doi: 10.1093/jtm/taz067.

引用本文的文献

1
Malaria chemoprophylaxis: cross-sectional study of use among air travellers departing from Accra, Ghana.疟疾化学预防:对从加纳阿克拉出发的航空旅客使用情况的横断面研究。
Malariaworld J. 2017 Feb 28;8:2. doi: 10.5281/zenodo.10756885. eCollection 2017.
2
Achieving malaria testing and treatment targets for children under five in Mozambique: a cost-effectiveness analysis.实现莫桑比克五岁以下儿童疟疾检测和治疗目标:成本效益分析。
Malar J. 2022 Nov 7;21(1):320. doi: 10.1186/s12936-022-04354-9.
3
Economic evaluation of severe malaria in children under 14 years in Zambia.

本文引用的文献

1
Canadian recommendations for the prevention and treatment of malaria among international travellers--2009.《2009年加拿大国际旅行者疟疾预防与治疗建议》
Can Commun Dis Rep. 2009 Jul;35 Suppl 1:1-82.
2
Malaria chemoprophylaxis: strategies for risk groups.疟疾化学预防:针对风险群体的策略
Clin Microbiol Rev. 2008 Jul;21(3):466-72. doi: 10.1128/CMR.00059-07.
3
The low and declining risk of malaria in travellers to Latin America: is there still an indication for chemoprophylaxis?前往拉丁美洲旅行者感染疟疾的风险较低且呈下降趋势:是否仍有进行化学预防的指征?
赞比亚14岁以下儿童重症疟疾的经济评估。
Cost Eff Resour Alloc. 2022 Feb 5;20(1):4. doi: 10.1186/s12962-022-00340-9.
4
Malaria in tunisian military personnel after returning from external operation.从海外行动返回后的突尼斯军事人员中的疟疾
Malar Res Treat. 2013;2013:359192. doi: 10.1155/2013/359192. Epub 2013 May 23.
Malar J. 2007 Aug 23;6:114. doi: 10.1186/1475-2875-6-114.
4
[Severe imported malaria. The experience of the military hospital of Marrakech].[严重输入性疟疾。马拉喀什军事医院的经验]
Ann Biol Clin (Paris). 2006 Sep-Oct;64(5):501-5.
5
Malaria prophylaxis policy for travellers from Europe to the Indian Subcontinent.针对从欧洲前往印度次大陆旅行者的疟疾预防政策。
Malar J. 2006 Feb 1;5:7. doi: 10.1186/1475-2875-5-7.
6
Who needs drug prophylaxis against malaria? My personal view.谁需要疟疾药物预防?我的个人观点。
J Travel Med. 2005 Jul-Aug;12(4):217-21. doi: 10.2310/7060.2005.12408.
7
[Malaria in the emergency room. Results of the emergency treatment of 137 patients with symptomatic malaria].[急诊室中的疟疾。137例有症状疟疾患者的急诊治疗结果]
Dtsch Med Wochenschr. 2005 Jan 28;130(4):145-9. doi: 10.1055/s-2005-837386.
8
Imported malaria at an inner-city hospital in the United States.美国一家市中心医院的输入性疟疾
Am J Med Sci. 2005 Jan;329(1):6-12. doi: 10.1097/00000441-200501000-00002.
9
Reemergence of malaria: increasing risks for travelers.
J Travel Med. 2001 Dec;8(Suppl 3):S42-7. doi: 10.2310/7060.2001.22421.
10
Imported malaria treated in Melbourne, Australia: epidemiology and clinical features in 246 patients.
J Travel Med. 2001 Mar-Apr;8(2):76-81. doi: 10.2310/7060.2001.24309.